Back

State of the Art - Novel therapies for acute myocardial infarction

3 September 2019 (11:20 - 11:34)
Organised by:
Congress Presentation Part of: Emerging treatments in acute coronary syndromes Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Gerd Heusch

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)

3 More presentations in this session

Presentation thumbnail
Inhibition of platelet aggregation after subcutaneous administration of a single-dose of selatogrel, a novel P2Y12 antagonist, in acute myocardial infarction: a randomised open-label phase 2 study
Professor P. Sinnaeve (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Interleukin-1 blockade with Anakinra in ST-segment elevation acute myocardial infarction: Results from the VCUART3 study
Doctor A. Abbate (Charlottesville, US)
Abstract Slides Video
Presentation thumbnail
KAND567, the first selective small molecule CX3CR1 antagonist in clinical development, mediates anti-inflammatory cardioprotective effects in rodent models of atherosclerosis and myocardial infarction
Professor I. Spyridopoulos (Newcastle-Upon-Tyne, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Emerging treatments in acute coronary syndromes

The Event

Event poster

ESC Congress 2019

3 September 2019 11:20 CET
You may be interested in
thumbnail
Congress Session
2023 ESC Guidelines for the Management of Acute Coronary Syndromes
28 August 2023
thumbnail
Congress Session
New frontiers in heart failure therapies
19 May 2025
thumbnail
Congress Presentation
1 September 2019
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources